Collegium Pharmaceutical (COLL) Change in Account Payables (2014 - 2026)

Collegium Pharmaceutical has reported Change in Account Payables for 13 years, with the latest figure at $317000.0 in Q2 2026.

• On a quarterly basis, Change in Account Payables rose 104.55% year-over-year to $317000.0 in Q2 2026; TTM through Jun 2026 was -$3.7 million, a 305.71% decrease from a year earlier, with the FY2025 full-year figure at $6.7 million, up 159.57% from the prior year.
• Change in Account Payables was $317000.0 for Q2 2026 at Collegium Pharmaceutical, up from -$3.8 million in the prior quarter.
• The five-year high for Change in Account Payables was $13.9 million in Q1 2025, with the low at -$7.0 million in Q2 2025.
• Average Change in Account Payables over 5 years is -$206444.4, with a median of -$426000.0 recorded in 2022.
• The sharpest annual moves came in 2024 and 2025: Change in Account Payables sank 603.3% in 2024, then jumped 648.86% in 2025.
• Over 5 years, Change in Account Payables stood at -$4.1 million in 2022, then surged by 219.6% to $5.0 million in 2023, then tumbled by 83.65% to $810000.0 in 2024, then soared by 275.93% to $3.0 million in 2025, then tumbled by 89.59% to $317000.0 in 2026.
• The last three Change in Account Payables figures came in at $317000.0 (Q2 2026), -$3.8 million (Q1 2026), and $3.0 million (Q4 2025), per Business Quant data.